Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00222911 · ClinicalTrials.gov registry record · Phase 4
Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports
A Phase 4 study of Plantar Fasciitis, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT00222911: Completed Phase 4 study of Plantar Fasciitis, sponsored by University of Pittsburgh.
NCT00222911 is a Phase 4 study of Plantar Fasciitis that has completed, run by University of Pittsburgh. The registered enrollment target is 75 participants, below the 97-participant average among 6 other Plantar Fasciitis trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00222911, a Phase 4 study of Plantar Fasciitis, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall purpose of this study is to examine the combined effect of both dorsiflexion night splints and medial arch supports and compare it to the effect of these interventions each by itself in the treatment of plantar fasciitis.
Conditions Studied
Interventions
- DEVICE dorsiflexion night splint
- DEVICE medial arch support
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-11 |
| Phase | Phase 4 |
What the finished NCT00222911 record still lists
NCT00222911 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 97-participant average among 6 other Plantar Fasciitis trials with a reported enrollment target (23% lower).
The record links to 1 condition, with Plantar Fasciitis appearing as the primary indexed condition, and to 2 interventions - of which dorsiflexion night splint is the first listed.
NCT00222911 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00222911 about?
NCT00222911 is a clinical study titled "Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports". The overall purpose of this study is to examine the combined effect of both dorsiflexion night splints and medial arch supports and compare it to the effect of these interventions each by itself in the treatment of plantar fasciitis.
What is the current status of trial NCT00222911?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2005-08. Estimated completion is 2006-11.
What conditions does trial NCT00222911 study?
This clinical trial studies the following conditions: Plantar Fasciitis.
What interventions are being tested in trial NCT00222911?
The interventions under investigation include: dorsiflexion night splint (DEVICE), medial arch support (DEVICE).
Who is sponsoring clinical trial NCT00222911?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00222911 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plantar Fasciitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lateral Plantar Artery Embolization For Plantar Fasciitis
RECRUITING · Phase 1
-
The Effects of Terrain Variation on Intrinsic Foot Musculature in Healthy Individuals and Individuals With Plantar Fasciitis
RECRUITING · NA
-
Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
COMPLETED · Phase 2
-
Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome
COMPLETED · Phase 3
-
DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
COMPLETED · Phase 2
-
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia